This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Naito S , Ichiyanagi O , Ito H , Kabasawa T , Kanno H , Narisawa T , Fukuhara H , Yagi M , Kurota Y , Yamagishi A , Sakurai T , Nishida H , Kawazoe H , Yamanobe T , Kato T , Makhov P , Kolenko VM , Yamakawa M , Tsuchiya N
Expression of total and phospho 4EBP1 in metastatic and non-metastatic renal cell carcinoma
Oncol Lett. 2019 Apr;17(4) :3910-3918
PMID: 30881508 PMCID: PMC6403496
AbstractEukaryotic translation initiation factor 4E-binding protein 1 (4EBP1) is phosphorylated and activated by mammalian target of rapamycin complex 1, which serves as a regulator of cell growth, cell survival, metastasis and angiogenesis in many types of cancer. The aim of this study was to evaluate the role of phosphorylated 4EBP1 (p4EBP1) in primary renal cell carcinoma (RCC) as a biomarker in metastatic RCC (mRCC) and non-mRCC cohorts. Primary tumor tissue from 254 non-mRCC and 60 mRCC patients were immunohistochemically stained for t4EBP1 and p4EBP1. The disease-free interval (DFI) categorized by the expressions and clinical parameters were assessed by univariate and multivariate analysis in the non-mRCC cohort. Then, the cause-specific survival (CSS) was assessed in the mRCC cohort by the same methods as used in the non-mRCC cohort. In the non-mRCC cohort, patients with t4EBP1 expression had no RCC recurrence. Patients with p4EBP1 expression had the shorter DFI in univariate analysis (P=0.037). p4EBP1 and pT1b-4 expression levels were independent predictors for de novo metastasis. In the mRCC cohort, intermediate/poor MSKCC risk, non-clear cell RCC, and no p4EBP1 expression were correlated with poor CSS on multivariate analysis. Expression of p4EBP1 could be a predictive biomarker for de novo metastasis in non-mRCC patient cohort. By contrast, mRCC patients showing no p4EBP1 expression had shorter CSS than patients with p4EBP1 expression.
NotesNaito, Sei Ichiyanagi, Osamu Ito, Hiromi Kabasawa, Takanobu Kanno, Hidenori Narisawa, Takafumi Fukuhara, Hiroki Yagi, Mayu Kurota, Yuta Yamagishi, Atsushi Sakurai, Toshihiko Nishida, Hayato Kawazoe, Hisashi Yamanobe, Takuya Kato, Tomoyuki Makhov, Peter Kolenko, Vladimir M Yamakawa, Mitsunori Tsuchiya, Norihiko Journal Article Greece Oncol Lett. 2019 Apr;17(4):3910-3918. doi: 10.3892/ol.2019.10033. Epub 2019 Feb 12.